# Safety, Tolerability, and Pharmacokinetics of BGB-23339 in Healthy Japanese and Caucasian Subjects

> **NCT05387668** · PHASE1 · WITHDRAWN · sponsor: **BeiGene**

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BGB-23339
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05387668
- **Lead sponsor:** BeiGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02-17
- **Primary completion:** 2022-10-17
- **Final completion:** 2022-10-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor determined the data was no longer needed.
- **Last updated:** 2022-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05387668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05387668, "Safety, Tolerability, and Pharmacokinetics of BGB-23339 in Healthy Japanese and Caucasian Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05387668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*